Lancet 359:1929–1936PubMedCrossRef 59. Hui SL, Slemenda CW, Johnston C (1998) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809CrossRef 60. Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037PubMedCrossRef 61. Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid
use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef 62. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef 63. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman J (2006) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162CrossRef 64. De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a predictor of fracture risk: Sapanisertib molecular weight a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef 65. Klotzbuecher CM, Ross PD, Landsman PD, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical
synthesis. J Bone Miner Res 15:721–739PubMedCrossRef 66. Kanis JA, McCloskey E, Johansson H, Oden A, learn more Leslie WD (2012) FRAX® with and without bone mineral density. Calcif Tissue Int 90:1–13PubMedCrossRef 67. Schwartz AV, Vittinghoff E, Bauer DC et al (2011)
Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192PubMedCrossRef 68. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27:301–308PubMedCrossRef 69. Nguyen ND, Frost Avelestat (AZD9668) SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431–1444PubMedCrossRef 70. Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 339:b4229PubMedCrossRef 71. McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef 72. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11(Suppl 6):S2–S17PubMedCrossRef 73. Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA (2002) Biochemical JQ1 indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13:523–526PubMedCrossRef 74.